T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report

doi:10.12998/wjcc.v11.i26.6200

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2642)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

WORD

HTML

1383

Figures (1-2)

213

Sum=1662

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

216

Download

282

Sum=498

Publishing Process of This Article

Item

Count

Browse

111

Download

233

Sum=344

Sep 16, 2023 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Sep 16, 2023; 11(26): 6200-6205
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6200

Full Size Figure Download Figure

Figure 2 Summary of the absolute neutrophil counts from initiating vincristine, prednisolone, daunorubicin, and l-asparaginase therapy to the end of the second venetoclax/decitabine cycle. VDPL: Vincristine, prednisolone, daunorubicin, and l-asparaginase.

Citation: Park S, Jeong EJ, Kang JH, Lee GW, Go SI, Lee DH, Koh EH. T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report. World J Clin Cases 2023; 11(26): 6200-6205
URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6200.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6200